A clinical study with the New York University (NYU) School of Medicine aims at advancing diagnosis and treatment of kidney and prostate cancer through imaging and 3D printing.
The two-year clinical trial
Nicole Wake – a pre-doctoral researcher at the Sackler Institute of Graduate Biomedical Sciences at NYU School of Medicine will conduct this research.
She will analyze how patient-specific multi-colored physical tumor models, printed on the Stratasys J750 3D Printer, can potentially change and improve the quality of patient care.
These patient-specific 3D models of organs and their associated pathologies may empower surgeons and researchers to conduct more accurate pre-operative assessment and inter-operative guidance, potentially improving surgical outcomes.
3D printing holds a lot of potential in assisting with surgical planning, and as surgeons, we are always looking at ways to improve outcomes for our patients,” says study co-author William C. Huang, MD, associate professor of urology at NYU School of Medicine. “We are pleased to be leading a study examining how 3D-printed models may improve the surgical planning process and ultimately impact patient care.”
Stratasys J750 3D Printer
With its unique ability to produce parts in over 360,000 colors, textures, gradients, and transparencies – the Stratasys J750 3D Printer delivers medical models with a broad array of characteristics that replicate the look, feel and function of organic structures.
Stratasys will be present at COMPAMED to demonstrate 3D printing’s advancements in the medical sector.
The clinical study is expected to continue into 2018. During the next phase of the project, researchers will begin to explore quantitative patient outcomes.
For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter!
//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
(adsbygoogle = window.adsbygoogle || []).push({});